These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 31916312)
1. Novel classifiers with clinical laboratory parameters for early detection of osteosarcoma. Cao LL; Chen Z; Yue Z; Pei L; Jia M; Wang H; Li T J Clin Lab Anal; 2020 May; 34(5):e23189. PubMed ID: 31916312 [TBL] [Abstract][Full Text] [Related]
2. Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcoma. Kim SH; Shin KH; Moon SH; Jang J; Kim HS; Suh JS; Yang WI Cancer Med; 2017 Jun; 6(6):1311-1322. PubMed ID: 28493412 [TBL] [Abstract][Full Text] [Related]
3. High serum alkaline phosphatase cooperating with MMP-9 predicts metastasis and poor prognosis in patients with primary osteosarcoma in Southern China. Han J; Yong B; Luo C; Tan P; Peng T; Shen J World J Surg Oncol; 2012 Feb; 10():37. PubMed ID: 22333159 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma. Ma B; Li M; Zhang L; Huang M; Lei JB; Fu GH; Liu CX; Lai QW; Chen QQ; Wang YL Tumour Biol; 2016 Apr; 37(4):4445-55. PubMed ID: 26499949 [TBL] [Abstract][Full Text] [Related]
5. A New Classifier Based on Laboratory Indicators for Early Diagnosis and Prognosis Prediction of Ewing's Sarcoma. Cao LL; Yang L; Chen Z; Yue Z; Pei L; Jia M; Wang H; Li T Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255301 [TBL] [Abstract][Full Text] [Related]
6. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma. Huang C; Wang Q; Ma S; Sun Y; Vadamootoo AS; Jin C Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286 [TBL] [Abstract][Full Text] [Related]
7. Bone-specific alkaline phosphatase in plasma as tumour marker for osteosarcoma. Liu PP; Leung KS; Kumta SM; Lee KM; Fung KP Oncology; 1996; 53(4):275-80. PubMed ID: 8692530 [TBL] [Abstract][Full Text] [Related]
8. Identification of Biomarkers for Osteosarcoma Based on Integration Strategy. Bao J; Song Z; Song C; Wang Y; Li W; Mai W; Shi Q; Yu H; Ni L; Liu Y; Lu X; He C; Chen L; Qu G Med Sci Monit; 2020 Mar; 26():e920803. PubMed ID: 32173717 [TBL] [Abstract][Full Text] [Related]
9. A novel assessment method of serum alkaline phosphatase for the diagnosis of osteosarcoma in children and adolescents. Shimose S; Kubo T; Fujimori J; Furuta T; Ochi M J Orthop Sci; 2014 Nov; 19(6):997-1003. PubMed ID: 25100572 [TBL] [Abstract][Full Text] [Related]
10. Identification of circulating miR-663a as a potential biomarker for diagnosing osteosarcoma. Huang C; Sun Y; Ma S; Vadamootoo AS; Wang L; Jin C Pathol Res Pract; 2019 Jun; 215(6):152411. PubMed ID: 30987831 [TBL] [Abstract][Full Text] [Related]
11. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma. Wang B; Tu J; Yin J; Zou C; Wang J; Huang G; Xie X; Shen J Oncotarget; 2015 Nov; 6(35):38348-59. PubMed ID: 26435480 [TBL] [Abstract][Full Text] [Related]
12. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma. Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796 [TBL] [Abstract][Full Text] [Related]
13. Does serum alkaline phosphatase level really indicate the prognosis in patients with osteosarcoma? A meta-analysis. Gu R; Sun Y J Cancer Res Ther; 2018 Jun; 14(Supplement):S468-S472. PubMed ID: 29970708 [TBL] [Abstract][Full Text] [Related]
14. Long Noncoding MT1JP Enhanced the Inhibitory Effects of miR-646 on FGF2 in Osteosarcoma. Yang L; Liu G; Xiao S; Wang L; Liu X; Tan Q; Li Z Cancer Biother Radiopharm; 2020 Jun; 35(5):371-376. PubMed ID: 32196384 [No Abstract] [Full Text] [Related]
15. Serum CEACAM1 Level Is Associated with Diagnosis and Prognosis in Patients with Osteosarcoma. Yu H; Yu J; Ren Y; Yang Y; Xiao X PLoS One; 2016; 11(4):e0153601. PubMed ID: 27074014 [TBL] [Abstract][Full Text] [Related]
16. A novel prognostic model for osteosarcoma using circulating CXCL10 and FLT3LG. Flores RJ; Kelly AJ; Li Y; Nakka M; Barkauskas DA; Krailo M; Wang LL; Perlaky L; Lau CC; Hicks MJ; Man TK Cancer; 2017 Jan; 123(1):144-154. PubMed ID: 27529817 [TBL] [Abstract][Full Text] [Related]
17. Identification of osteosarcoma-related specific proteins in serum samples using surface-enhanced laser desorption/ionization-time-of-flight mass spectrometry. Gu J; Li J; Huang M; Zhang Z; Li D; Song G; Ding X; Li W J Immunol Res; 2014; 2014():649075. PubMed ID: 24872957 [TBL] [Abstract][Full Text] [Related]
18. Three hematological indexes that may serve as prognostic indicators in patients with primary, high-grade, appendicular osteosarcoma. Hu K; Wang Z; Lin P; Wen Z; Ren H; Sun L; Li H; Li B; Wang S; Zhou X; Tengwang S; Xu L; Ye Z Oncotarget; 2017 Jun; 8(26):43130-43139. PubMed ID: 28562345 [TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of circulating serum amyloid A and CXC chemokine ligand 4 in osteosarcoma. Flores RJ; Kelly AJ; Li Y; Chen X; McGee C; Krailo M; Barkauskas DA; Hicks J; Man TK Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28544777 [TBL] [Abstract][Full Text] [Related]
20. Analysis of circulating long non-coding RNA UCA1 as potential biomarkers for diagnosis and prognosis of osteosarcoma. Wen JJ; Ma YD; Yang GS; Wang GM Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):498-503. PubMed ID: 28239821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]